Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:33 AM
Ignite Modification Date:
2025-12-25 @ 4:33 AM
NCT ID:
NCT05813418
Eligibility Criteria:
Inclusion Criteria:
* patient with cancer, whatever initial tumoral histology and disease stage under ICPI treatment (anti-PD1 and/or anti-CTLA-4)
* age \> 18
* followed in oncology, pneumology, dermatology, gastroenterology departments of Amiens-Picardie University Hospital or Saint Quentin hospital
* who received verbal and written information, and signed the consent form for the study
Exclusion Criteria:
* non ICPI treated patients
* patient who received a first line of ICPI treatment
* patient who received or is receiving MEK inhibitors as a treatment (because of possible lower response to ICPI treatment when associated)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05813418
Study Brief:
Protocol Section:
NCT05813418